Clinical development and Perspectives of CImAvax EgF, Cuban Vaccine for Non-small-cell Lung Cancer therapy
by hamit | Jun 25, 2017 | medical-articles |
Recent Posts
- CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer
- Immunotherapy and lung cancer: current developments and novel targeted therapies
- CiMAvax-eGF: A New Therapeutic vaccine for Advanced Non-Small Cell Lung Cancer Patients
- Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients
- “Why an American went to Cuba for cancer care”
Recent Comments